[ET Net News Agency, 30 December 2025] Morgan Stanley lowered the target price for Trad
Chi Med (00570) to HKD1.5 from HKD1.6 and maintained the "underweight" rating.
The research house said it cuts 2025-30e earnings by 10-14%, factoring in more
impairment charges related to TCM formula granule price cuts. (rc)
|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00570 TRAD CHI MED
Nominal 
2.160 -0.010 (-0.461%) Others
30/12/2025 16:04
{I-bank focus}Morgan lowers Trad Chi Med (00570) to HKD1.5
Next︰16/10/2025 10:51 {Hot Stocks}TRAD CHI MED(00570) quoted at HK$2.62, up 7.4%
25/09/2025 10:00 {Hot Stocks}TRAD CHI MED(00570) quoted at HK$2.37, down 5.2%
24/09/2025 15:45 {Hot Stocks}TRAD CHI MED(00570) quoted at HK$2.46, up 14.4%
24/09/2025 11:27 {Hot Stocks}TRAD CHI MED(00570) quoted at HK$2.37, up 10.2%
24/09/2025 11:15 {Hot Stocks}TRAD CHI MED(00570) quoted at HK$2.26, up 5.1%
01/08/2025 13:33 {Hot Stocks}TRAD CHI MED(00570) quoted at HK$2.35, up 4.9%
| Remark: | Real time quote last updated: 07/01/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service |